Skip to content

Advertisement

Multidisciplinary Respiratory Medicine

What do you think about BMC? Take part in

Upcoming special issue

The best abstracts of the 2nd World Bronchiectasis Conference will be published in Multidisciplinary Respiratory Medicine as part of a special issue on Bronchiectasis.

New Content Item​​​​​​​

Articles

View all articles
  1. Content type: Review

      |  

    Authors: Dewi Nurul Makhabah, Federica Martino and Nicolino Ambrosino

View all articles

Aims and scope

Multidisciplinary Respiratory Medicine is the official journal of the Italian Respiratory Society - Società Italiana di Pneumologia (IRS/SIP). The journal publishes on all aspects of respiratory medicine and related fields, with a particular focus on interdisciplinary and translational research.

The interdisciplinary nature of the journal provides a unique opportunity for researchers, clinicians and healthcare professionals across specialties to collaborate and exchange information. The journal provides a high visibility platform for the publication and dissemination of top quality original scientific articles, reviews and important position papers documenting clinical and experimental advances.

Given the journal’s interdisciplinary character, the target readership is wider than respiratory medicine, embracing numerous related disciplines (allergology, immunology, internal medicine, geriatrics, infectious diseases, intensive care, etc) and health professionals.

Discounts for BioMed Central members

BioMed Central has a total of 522 Members across 56 countries, including 14 Italian institutions. Members can benefit from discounted or waived article processing charges (APCs) when publishing in Multidisciplinary Respiratory Medicine. Click here to find out more about our member institutions.

Sign up to receive article alerts

Multidisciplinary Respiratory Medicine is published continuously online-only and so we encourage you to sign up to receive free email alerts to keep up to date with all of the latest research by registering here.

Featured review: Recent advances in capsule-based dry powder inhaler technology

Pulmonary drug delivery is currently the focus of accelerated research and development because of the potential to produce maximum therapeutic benefit to patients by directly targeting drug to the site of pathology in the lungs. Among the available delivery options, the dry powder inhaler (DPI) is the preferred device for the treatment of an increasingly diverse range of diseases. This article reviews recent advances in capsule-based DPI technology and the introduction of the ‘disposable’ DPI device.


Read the article

Featured article: Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice

The intratracheal instillation of bleomycin in mice induces early damage to alveolar epithelial cells and development of inflammation followed by fibrotic tissue changes. Histopathology is the gold standard for assessing lung fibrosis in rodents, however it precludes repeated and longitudinal measurements of disease progression. This study investigates the use of the Micro-CT technique to allow the evaluation of disease onset and progression at different time-points in the mouse bleomycin model of lung fibrosis. 

Read the article

Editors' profiles

New Content Item

Francesco Blasi,  Editor-in-Chief

Francesco Blasi, MD, FERS is a Professor of Respiratory Medicine at the Department of Pathophysiology and Transplantation of the University of Milan. Additionally, he is Head of the Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center IRCCS Fondazione Cà Granda Ospedale Maggiore in Milan . Prof Blasi is a former President of European Respiratory Society (ERS) 2012-13 and past President of the Italian Respiratory Society (SIP/IRS). He is currently serving as President of the Italian Respiratory Society Research Center  2017-2018. Prof Blasi has published more than 300 papers in International Journals. His research interests include pneumonia, COPD, bronchiectasis, cystic fibrosis and lung transplantation.

Claudio M Sanguinetti

Claudio Sanguinetti, Editor-in-Chief

Dr Claudio Sanguinetti is a senior consultant in respiratory medicine at the Quisisana Clinical Center in Rome, Italy. He has had many teaching appointments in respiratory medicine at Ancona University, and now teaches in a degree course of the Catholic University in Rome.

Advertisement

Official journal of

2016 Journal Metrics

  • Speed
    29 days from submission to first decision
    21 days from acceptance to publication

    Usage 
    160,501 downloads
    657.0 Usage Factor

    Social Media Impact
    49 mentions

Advertisement